Tripleflex Glucosamine Brands Tripleflex Glucosamine TINA.org objected — as amicus curiae — to a class-action settlement that sought to resolve claims that TripleFlex glucosamine supplements were deceptively marketed as being able to improve joint mobility,…
Move Free Glucosamine Brands Move Free Glucosamine TINA.org, along with AARP, objected — as amici curiae — to a class-action settlement that sought to resolve claims filed against Schiff Nutrition for deceptively marketing Move Free® Advanced glucosamine…
Steuart’s Pain Formula Ad Alert Steuart’s Pain Formula Natural pain relief claims referred to federal agency for review.
2016/2019 Kyäni Health Claims Evidence 2016/2019 Kyäni Health Claims A TINA.org investigation initially cataloged more than 100 instances in which Kyani distributors either made or referenced claims that the Kyani product lines can treat, cure, alleviate the symptoms of,…
Reckitt Benckiser Brands Reckitt Benckiser TINA.org objected — as amicus curiae — to two class-action settlements that pertain to the marketing of Reckitt Benckiser products: Neuriva, a brain supplement falsely labeled as “clinically proven” to…
Lawsuits: Glucosamine’s Promised Relief Mostly Marketing Hype Consumer News Lawsuits: Glucosamine’s Promised Relief Mostly Marketing Hype Consumers report adverse reactions.
Le-Vel Health Claims Evidence Le-Vel Health Claims A TINA.org investigation has cataloged more than 50 instances from 2016 to 2020 in which Le-Vel and/or its distributors have either made or referenced claims that the Thrive product line…
Doggie Dailies Ad Alert Doggie Dailies Dog supplement manufacturer makes changes to Amazon listing following TINA.org inquiry.
Consumers Claim This Joint is Not Jumping Consumer News Consumers Claim This Joint is Not Jumping Multiple class actions filed about glucosamine.
Joint Juice Class Action Joint Juice February 2019: This case was transferred to federal court. (Case No. 19-cv-875, N. D. CA.) January 2019: A class-action lawsuit was filed against Premier Nutrition for allegedly falsely advertising that…
Neurolumen Ad Alert Neurolumen Brochure for medical device targeted military members with illegal claims to treat PTSD, among other diseases.
The Willow Curve Ad Alert The Willow Curve Futuristic-looking device promises relief from nerve and joint pain but clinical trials appear to be lacking.
Natural Joint Defence Ad Alert Natural Joint Defence UK ad watchdog bans arthritis supplement’s health claims.
Ad Watchdog TINA.org Objects to Unfair Class Action Settlement Press Release Ad Watchdog TINA.org Objects to Unfair Class Action Settlement Lawyers To Pocket $4 Million in Glucosamine Deal MADISON, CONN. Nov. 15, 2017 – Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes…
Glucosamine Settlement Is a Raw Deal for Consumers Consumer News Glucosamine Settlement Is a Raw Deal for Consumers TINA.org objects to proposed settlement in which marketer and plaintiffs’ attorneys are the only winners.
Jusuru Health Claims Evidence Jusuru Health Claims A TINA.org investigation has cataloged over 50 instances from 2010 to 2016 in which Jusuru distributors have either made or referenced claims that the Jusuru product line can treat, cure, alleviate the symptoms…
Walgreens Ear Pain Relief and Ear Ache Drops Class Action Walgreens Ear Pain Relief and Ear Ache Drops January 2015: A federal judge granted the parties’ joint motion for dismissal. The reasons for the dismissal have not yet been disclosed. February 2014: A false advertising class-action lawsuit alleging…
Tommie Copper Ad Alert Tommie Copper Company agrees to pay $1.35 million to settle deceptive advertising charges about its copper-infused compression clothing.